-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN vitamin) (NN A) (NN status)) (PP (IN during) (NP (NP (NN infection)) (PP (IN in) (NP (JJ hospitalised) (NNS children))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NP (DT the) (JJ molar) (NN ratio)) (PP (IN of) (NP (NP (NN serum) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (NN vitamin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN VA)) (-RRB- -RRB-))) (NN status)) (PP (IN during) (NP (NN infection)))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN DESIGN)) (: :) (S (NP (PRP We)) (VP (VBD took) (NP (NP (NN advantage)) (PP (IN of) (NP (ADJP (RB previously) (VBN collected)) (NNS data)))) (PP (IN during) (NP (DT a) (JJ randomised) (ADJP (ADJP (JJ double-blind)) (, ,) (ADJP (JJ placebo-controlled))) (JJ clinical) (NN trial))) (S (VP (TO to) (VP (VB conduct) (NP (NP (NP (DT a) (JJ secondary) (NN analysis)) (PP (IN of) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN ratio)))) (CC and) (NP (NP (PRP$ its) (NN relationship)) (PP (TO to) (NP (NP (NN infection)) (CC and) (NP (NN VA) (NN status))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ MAIN) (NN OUTCOME) (NNS MEASURES)) (: :) (NP (NP (NN _PROT1_AND_PROT2_) (JJ molar) (NN ratio)) (PP (IN after) (NP (CD 7) (NNS days) (NN hospitalisation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT2_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT2_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT2_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT2_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT2_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT1_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT2_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT1_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT2_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT1_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT2_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT1_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT2_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT1_)))))) (: :) (S (NP (NP (NN _PROT2_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT1_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT2_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT1_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT2_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT1_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT2_) (: :) (NN _PROT_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT1_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT2_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NP (NP (NNS RESULTS) (: :) (S (S (PP (IN After) (NP (NP (NP (CD 7) (NNS days)) (NP (NN hospitalisation))) (, ,) (NP (NP (NP (JJ molar) (NN _PROT_) (: :) (NN _PROT_) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NN mean+/-s.d.)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ infected) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ C-reactive) (NN proteins>10) (NN mg/l)) (-RRB- -RRB-))) (VP (VBD was) (NP (CD 0.67+/-0.31)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (CD 0.74+/-0.44)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ low) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=71)) (-RRB- -RRB-))) (CC and) (NP (CD 0.73+/-0.39))) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD n=81)) (-RRB- -RRB-))))))) (. .))) (NP (DT These) (NNS values)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (JJ one-way) (NN ANOVA) (NN P=0.472)) (-RRB- -RRB-)))) (. .)) (FW In))) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN baseline) (NN serum) (NN retinol) (CD concentrations<0.70) (NN micromol/l)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN _PROT_)))))) (: :) (S (NP (NP (NN _PROT_) (NN ratio)) (PP (IN between) (NP (NP (NN admission)) (CC and) (NP (NN day) (CD 7))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ different) (PP (IN in) (NP (NP (DT the) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NN one-way) (NN ANOVA) (NN P=0.548)) (-RRB- -RRB-))))))) (. .))) (NNS CONCLUSIONS)) (: :) (S (PP (IN In) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (JJ malnourished) (JJ hospitalised) (NNS children))))) (, ,) (NP (JJ molar) (NN _PROT1_) (: :) (NN _PROT2_) (NN ratio)) (VP (VBZ does) (RB not) (VP (VBP appear) (VP (TO to) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NN VA) (NN status)) (PP (IN during) (NP (NP (NN infection.) (NN SPONSORSHIP)) (: :) (S (NP (PRP$ Our) (NN research)) (VP (VBD was) (ADVP (RB partially)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (NP (DT the) (NNP Fonds) (FW de) (NN la)) (NP (NNP Recherche) (NNP Scientifique) (FW et) (FW Medicale)) (PRN (-LRB- -LRB-) (NP (NN contract) (CD 3.4505.94)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NP (NNP David)) (CC and) (NP (NNP Alice) (NNP Van) (NNP Buuren) (NNP Foundation))))))))))))))))))))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT2_) (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT2_) (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (JJ cerebrospinal) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN CSF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ second-stage) (ADVP (FW Trypanosoma) (FW brucei))) (NN gambiense) (NN sleeping) (NN sickness)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NNS Correlations)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NNS _PROT2_)) (PP (IN in) (NP (NN CSF))) (PP (IN as) (NP (NP (NNS markers)) (PP (IN for) (NP (NP (NN astrogliosis)) (CC and) (NP (NN neurodegeneration)))))))))) (, ,) (CC and) (NP (ADJP (ADJP (JJ clinical)) (CC and) (ADJP (JJ biological))) (NNS data))) (VP (VBD were) (VP (VBN investigated)))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (JJ Abnormal) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN associated) (PP (PP (IN with) (S (VP (VBG increasing) (NP (NP (NN CSF) (NN cell) (NN number)) (CC and) (NP (NN protein) (NN concentration)))))) (, ,) (CC and) (PP (IN with) (NP (NP (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN lymph) (NNS nodes)))) (CC or) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS trypanosomes))))) (PP (IN in) (NP (NP (NN lymph) (NN node)) (NN aspirate))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT2_) (NN _PROT2_) (NNS _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT1_) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_)) (CD _PROT1_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT1_) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_)) (CD _PROT1_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT1_) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_)) (CD _PROT1_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN _PROT1_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN _PROT1_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN population) (NNS studies)))) (VP (VBP have) (VP (VBN explored) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ ischaemic) (NN heart) (NN disease))) (PP (IN with) (NP (NP (NN gene) (NNS polymorphisms)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS molecules) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NN beta))) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (CD 2))) (, ,) (NP (NN _PROT_) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)) (CD _PROT_)) (CC and) (NP (NP (PRP$ its) (NN receptor) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN receptor)) (PP (IN for) (NP (NN lipopolysaccharide)))) (-RRB- -RRB-))) (, ,) (NP (NN P) (CC and) (NN E) (NNS selectins)) (, ,) (CC and) (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)) (CD _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (JJ Present) (NNS data)) (VP (VBG concerning) (NP (NP (DT the) (JJ _PROT1_AND_PROT2_) (NN system)) (PP (IN of) (NP (JJ extrarenal) (NN origin)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT2_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT2_)) (NP (NN _PROT2_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT1_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT1_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT1_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT2_)) (NP (NN _PROT2_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT1_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT2_)) (NP (NN _PROT2_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT2_)) (NP (NN _PROT2_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT_)) (NP (NN _PROT_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN After) (NP (NP (DT a) (JJ brief) (JJ historical) (NN incursion)) (PP (VBG regarding) (NP (NP (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin))))))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT the) (JJ main) (JJ extrarenal) (JJ _PROT_) (NNS enzymes)) (, ,) (S (VP (VP (VBG starting) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN D)) (CC and) (NP (NN _PROT1_)) (NP (NN _PROT1_))))) (CC and) (VP (VBG ending) (PP (IN with) (NP (DT the) (NP (NN conversion) (NN enzyme)) (CC and) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (NN end))) (NP (PRP we)) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (NNS relations)) (PP (IN between) (NP (NP (NP (JJ circulating) (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin)))) (CC and) (NP (NP (DT the) (JJ extrarenal) (NN _PROT2_)) (ADJP (JJ specific) (PP (TO to) (NP (NP (NN tissue)) (VP (VBG underlying) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (DT the) (CD two) (NN _PROT_) (NNS components)) (VP (VP (VBP cooperate)) (CC and) (VP (VB constitute) (NP (NP (DT a) (JJ unitary) (JJ hormonal) (NN system)) (, ,) (VP (VP (VBG regulating) (NP (NP (DT the) (JJ major) (NNS functions)) (PP (IN of) (NP (DT the) (NN organism))))) (CC and) (VP (VBG maintaining) (NP (DT the) (JJ main) (JJ homeostatic) (NN equilibria)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (NN end))) (NP (PRP we)) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (NNS relations)) (PP (IN between) (NP (NP (NP (JJ circulating) (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin)))) (CC and) (NP (NP (DT the) (JJ extrarenal) (NN _PROT_)) (ADJP (JJ specific) (PP (TO to) (NP (NP (NN tissue)) (VP (VBG underlying) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (DT the) (CD two) (NN _PROT2_) (NNS components)) (VP (VP (VBP cooperate)) (CC and) (VP (VB constitute) (NP (NP (DT a) (JJ unitary) (JJ hormonal) (NN system)) (, ,) (VP (VP (VBG regulating) (NP (NP (DT the) (JJ major) (NNS functions)) (PP (IN of) (NP (DT the) (NN organism))))) (CC and) (VP (VBG maintaining) (NP (DT the) (JJ main) (JJ homeostatic) (NN equilibria)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (NN end))) (NP (PRP we)) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (NNS relations)) (PP (IN between) (NP (NP (NP (JJ circulating) (NN _PROT_)) (PP (IN of) (NP (JJ renal) (NN origin)))) (CC and) (NP (NP (DT the) (JJ extrarenal) (NN _PROT1_)) (ADJP (JJ specific) (PP (TO to) (NP (NP (NN tissue)) (VP (VBG underlying) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (DT the) (CD two) (NN _PROT2_) (NNS components)) (VP (VP (VBP cooperate)) (CC and) (VP (VB constitute) (NP (NP (DT a) (JJ unitary) (JJ hormonal) (NN system)) (, ,) (VP (VP (VBG regulating) (NP (NP (DT the) (JJ major) (NNS functions)) (PP (IN of) (NP (DT the) (NN organism))))) (CC and) (VP (VBG maintaining) (NP (DT the) (JJ main) (JJ homeostatic) (NN equilibria)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (SBAR (IN While) (S (NP (NP (DT the) (JJ circulating) (NN _PROT1_)) (PP (IN of) (NP (JJ renal) (NN origin)))) (VP (VBZ is) (ADVP (RB acutely)) (VP (VBN activated) (S (VP (TO to) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN accomplishment)) (PP (IN of) (NP (JJ short) (NN term) (JJ homeostatic) (NNS reactions)))))))))))) (, ,) (NP (NN tissue) (NN _PROT2_)) (, ,) (PP (IN in) (NP (ADJP (ADJP (JJ paracrine)) (CC or) (ADJP (JJ autocrine))) (NNS ways))) (, ,) (VP (VBZ exerts) (NP (NP (JJ local-regional) (JJ adaptive) (NNS actions)) (PP (IN of) (NP (JJ long) (NN duration))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Differential) (NN expression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))) (PP (IN by) (NP (NP (NP (NN NK) (NNS cells)) (PP (IN in) (NP (NN cancer) (NNS patients)))) (CC and) (NP (NP (NN correlation)) (PP (IN of) (NP (NP (JJ impaired) (NN _PROT_) (NN expression) (NN withprogression)) (PP (IN of) (NP (NN cancer)))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Differential) (NN expression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))) (PP (IN by) (NP (NP (NP (NN NK) (NNS cells)) (PP (IN in) (NP (NN cancer) (NNS patients)))) (CC and) (NP (NP (NN correlation)) (PP (IN of) (NP (NP (JJ impaired) (NN _PROT2_) (NN expression) (NN withprogression)) (PP (IN of) (NP (NN cancer)))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Differential) (NN expression)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))) (PP (IN by) (NP (NP (NP (NN NK) (NNS cells)) (PP (IN in) (NP (NN cancer) (NNS patients)))) (CC and) (NP (NP (NN correlation)) (PP (IN of) (NP (NP (JJ impaired) (NN _PROT2_) (NN expression) (NN withprogression)) (PP (IN of) (NP (NN cancer)))))))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (DT an) (NN effector) (NN molecule)) (VP (VBN co-localized) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (DT the) (JJ cytotoxic) (NNS granules)) (PP (IN of) (NP (NP (JJ cytotoxic) (NN T) (NNS lymphocytes)) (CC and) (NP (NP (NP (JJ natural) (NN killer)) (PRN (-LRB- -LRB-) (NP (NN NK)) (-RRB- -RRB-))) (NNS cells)))))))))))) (, ,) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB kill) (NP (NP (JJ intracellular) (NNS pathogens)) (PP (IN in) (NP (JJ infected) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN _PROT_))))))) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (DT a) (JJ cytotoxic) (NN effect)) (PP (IN against) (NP (NN tumor) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (DT an) (NN effector) (NN molecule)) (VP (VBN co-localized) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (NP (DT the) (JJ cytotoxic) (NNS granules)) (PP (IN of) (NP (NP (JJ cytotoxic) (NN T) (NNS lymphocytes)) (CC and) (NP (NP (NP (JJ natural) (NN killer)) (PRN (-LRB- -LRB-) (NP (NN NK)) (-RRB- -RRB-))) (NNS cells)))))))))))) (, ,) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB kill) (NP (NP (JJ intracellular) (NNS pathogens)) (PP (IN in) (NP (JJ infected) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN _PROT2_))))))) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (DT a) (JJ cytotoxic) (NN effect)) (PP (IN against) (NP (NN tumor) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (DT an) (NN effector) (NN molecule)) (VP (VBN co-localized) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (DT the) (JJ cytotoxic) (NNS granules)) (PP (IN of) (NP (NP (JJ cytotoxic) (NN T) (NNS lymphocytes)) (CC and) (NP (NP (NP (JJ natural) (NN killer)) (PRN (-LRB- -LRB-) (NP (NN NK)) (-RRB- -RRB-))) (NNS cells)))))))))))) (, ,) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB kill) (NP (NP (JJ intracellular) (NNS pathogens)) (PP (IN in) (NP (JJ infected) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN _PROT2_))))))) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (DT a) (JJ cytotoxic) (NN effect)) (PP (IN against) (NP (NN tumor) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB elucidate) (SBAR (IN whether) (S (NP (NP (JJ intracellular) (NN expression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))) (PP (IN by) (NP (NN NK) (NNS cells)))) (VP (MD might) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NN progression)) (PP (IN of) (NP (NN cancer))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT2_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT2_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT2_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT2_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Flow) (JJ cytometric) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_) (NN expression))))) (PP (IN by) (NP (NP (NP (NP (NP (NP (NN _PROT1_)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NN _PROT2_)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NNS cells)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN cancer) (NNS patients)) (VP (VBD exhibited) (NP (NP (ADJP (RB significantly) (VBN decreased)) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_) (NN expression)) (PRN (-LRB- -LRB-) (NP (NN P<0.005)) (-RRB- -RRB-))))) (, ,) (PP (IN despite) (S (VP (VBG having) (NP (NP (ADJP (RB equally) (JJ high)) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_) (NN expression)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ healthy) (NNS controls))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (JJ tumor-free) (NNS patients)) (VP (VBD expressed) (NP (NN _PROT1_)) (PP (IN at) (NP (NP (NNS levels)) (ADJP (JJ similar) (PP (TO to) (NP (JJ healthy) (NNS controls)))))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ progressive) (JJ tumor-bearing) (NNS patients)) (VP (VBD expressed) (NP (NP (ADJP (RB remarkably) (JJR lower)) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))) (PP (VBN compared) (PP (TO to) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN P<0.0001)) (-RRB- -RRB-)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (S (NP (NP (JJ impaired) (NN expression)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN NK) (NNS cells)))) (VP (VBZ correlates) (PP (IN with) (NP (NP (NN progression)) (PP (IN of) (NP (NN cancer))))))) (, ,) (CC and) (S (NP (NP (NN determination)) (PP (IN of) (NP (NN _PROT2_) (NN expression)))) (VP (MD might) (VP (VB prove) (ADJP (JJ informative) (PP (IN for) (S (VP (VBG assessing) (NP (NP (DT the) (JJ immunological) (NN condition)) (PP (IN of) (NP (NN cancer) (NNS patients)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN probed) (NP (NP (NP (DT an) (NN epitope) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN His18-Pro19-Lys20-Phe21)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (PP (IN by) (NP (JJ site-directed) (NN mutagenesis)))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT2_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT2_) (NN _PROT2_) (NNS _PROT2_) (NP (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_AND_PROT2_) (NN _PROT2_) (NNS _PROT2_) (NP (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT1_) (NN _PROT1_) (NNS _PROT1_) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT This) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ double))) (NN Ala) (NNS substitutions)) (PP (IN of) (NP (NP (NN His18)) (CC and) (NP (NN Phe21)))) (PP (IN in) (NP (NN _PROT_)))) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 77-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (PP (TO to) (NP (NN _PROT_) (NN _PROT_) (NNS _PROT_) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))))) (CC and) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT These) (NN Ala) (NNS mutants)) (VP (VP (VBD triggered) (NP (NN neutrophil) (NN degranulation))) (CC and) (VP (VBD induced) (NP (NP (NN calcium) (NNS responses)) (VP (VBN mediated) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NP (JJ Single) (NN Asp)) (CC or) (NP (NN Ser))) (NNS substitutions)) (, ,) (NP (NP (NP (NNP H18D) (, ,) (NNP F21D)) (, ,) (NP (NNP F21S)) (, ,) (CC and) (NP (JJ double) (NNS substitutions))) (, ,) (NP (NNP H18A/F21D) (, ,) (NNP H18A/F21S)) (, ,) (CC and) (NP (NNP H18D/F21D))) (, ,)) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 431-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NP (JJ Single) (NN Asp)) (CC or) (NP (NN Ser))) (NNS substitutions)) (, ,) (NP (NP (NP (NNP H18D) (, ,) (NNP F21D)) (, ,) (NP (NNP F21S)) (, ,) (CC and) (NP (JJ double) (NNS substitutions))) (, ,) (NP (NNP H18A/F21D) (, ,) (NNP H18A/F21S)) (, ,) (CC and) (NP (NNP H18D/F21D))) (, ,)) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 431-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NP (JJ Single) (NN Asp)) (CC or) (NP (NN Ser))) (NNS substitutions)) (, ,) (NP (NP (NP (NNP H18D) (, ,) (NNP F21D)) (, ,) (NP (NNP F21S)) (, ,) (CC and) (NP (JJ double) (NNS substitutions))) (, ,) (NP (NNP H18A/F21D) (, ,) (NNP H18A/F21S)) (, ,) (CC and) (NP (NNP H18D/F21D))) (, ,)) (VP (VBD reduced) (PRT (RP up)) (S (VP (TO to) (ADVP (RB 431-fold)) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (DT the) (NN _PROT_) (NN _PROT_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (DT the) (NN _PROT_) (NN _PROT_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (DT the) (NN _PROT2_) (NN _PROT2_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (DT the) (NN _PROT_) (NN _PROT_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (DT the) (NN _PROT2_) (NN _PROT2_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VP (VBZ recognizes)) (CC and) (VP (VBZ activates) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (DT the) (NN _PROT2_) (NN _PROT2_))) (PP (IN by) (NP (JJ distinct) (NNS mechanisms)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (S (NP (NN _PROT1_)) (VP (VBZ binds) (NP (JJ multiple) (NNS CC-chemokines)))) (: :) (S (NP (NN _PROT2_)) (VP (VBZ acts) (PP (IN as) (NP (DT a) (JJ natural) (NN antagonist)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VP (VBD was) (ADVP (RB first)) (VP (VBN characterized) (PP (IN as) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_)))))))) (, ,) (CC and) (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT the) (JJ main) (NN coreceptor)) (PP (IN for) (NP (JJ M-tropic) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (CD -1) (NNS strains)))) (CC and) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT All) (NNS CC-chemokines)) (ADJP (RB currently) (JJ available))) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN ability) (S (S (VP (TO to) (VP (VB compete) (PP (IN with) (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125) (-RRB- -RRB-) (CD I)) (-RRB- -RSB-)) (NN _PROT1_) (NN binding))) (PP (IN on) (NP (NP (DT a) (JJ stable) (NN cell) (NN line)) (VP (VBG expressing) (NP (JJ recombinant) (NN _PROT2_)))))))) (, ,) (CC and/or) (S (VP (TO to) (VP (VB induce) (NP (DT a) (JJ functional) (NN response)) (PP (IN in) (NP (DT these) (NNS cells)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT2_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT2_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT2_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT1_) (NN binding)) (: :) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT1_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT1_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT1_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT1_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))))) (, ,) (NP (CD five) (JJ other) (NNS CC-chemokines)) (VP (MD could) (VP (VB compete) (S (IN for) (S (NP (NP (-LRB- -LSB-) (PRN (-LRB- -LRB-) (NP (CD 125)) (-RRB- -RRB-)) (NN I) (-RRB- -RSB-) (NN _PROT_) (NN binding)) (: :) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_) (NN binding))) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NN IC) (-LRB- -LRB-) (CD 50) (-RRB- -RRB-) (NNS values)) (PP (IN of) (NP (QP (CD 0.22) (, ,) (CD 2.14) (, ,) (CD 5.89) (, ,) (CD 29.9) (, ,) (CC and) (CD 21.7)) (NN nmol/L))) (, ,) (ADVP (RB respectively)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT1_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT2_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT1_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT2_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT1_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT1_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT2_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT1_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT1_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT2_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT1_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT1_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT2_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT1_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT1_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT1_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT2_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT1_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN _PROT2_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN _PROT_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN Among) (NP (DT these) (NNS ligands))) (, ,) (NP (NN _PROT_)) (VP (VBD had) (NP (NP (DT the) (JJ remarkable) (NN property)) (PP (IN of) (NP (NP (NN binding) (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))))) (PP (IN without) (S (VP (VBG eliciting) (NP (NP (DT a) (JJ functional) (NN response)) (, ,) (S (NP (NN _PROT_)) (VP (VP (MD could) (ADVP (RB also)) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN _PROT1_)))))) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ natural) (NN antagonist)) (PP (IN for) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT1_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT2_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT1_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT2_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT1_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT2_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT1_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT1_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT2_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT1_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT2_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT1_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT2_))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT1_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT2_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT_))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT1_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NNS Chemokines)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB compete) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (IN for) (NP (NN _PROT_) (NN binding)))))))) (VP (MD could) (ADVP (RB also)) (VP (VB compete) (PP (IN for) (NP (JJ monomeric) (NN _PROT_) (NN binding))) (, ,) (ADVP (IN although) (PP (IN with) (NP (JJ variable) (NNS potencies))))))) (: ;) (S (NP (JJ maximal) (NN _PROT_) (NN binding) (NN inhibition)) (VP (VBD was) (NP (NP (NP (CD 80) (NN %)) (PP (IN for) (NP (NN _PROT1_)))) (, ,) (CONJP (CC but) (RB only)) (NP (NP (CD 30) (NN %)) (PP (IN for) (NP (NN _PROT2_))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (MD could) (VP (VB compete) (ADVP (RB efficiently)) (PP (IN for) (NP (NN _PROT2_) (NN binding))))) (CC but) (VP (VBD was) (, ,) (ADVP (RB however)) (, ,) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ weak) (NN inhibitor)) (PP (IN of) (NP (NN HIV) (NN infection)))) (, ,) (PP (ADVP (RB probably)) (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (PRP$ its) (NN inability) (S (VP (TO to) (VP (VB downregulate) (NP (DT the) (NN receptor)))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT1_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
+1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT1_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT1_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT2_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT1_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT2_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT2_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT2_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT2_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT2_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
+1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ individual) (NN amino) (NNS acids)) (PP (IN in) (NP (NP (NN _PROT_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN _PROT1_)) (VP (VBN involved) (PP (IN in) (NP (NP (NN binding)) (PP (TO to) (NP (NN _PROT2_)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (PP (IN in) (NP (DT this) (NN domain)))))))) (, ,) (NP (NP (DT the) (NN Trk) (NN amino) (NNS acids)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NN specificity)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT1_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT1_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT1_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ minimum) (NN set)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (NP (DT the) (JJ human) (JJ _PROT_) (JJ second) (JJ immunoglobulin-like) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB bind) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))))) (, ,)))))) (VP (VBD were) (VP (VBN substituted) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (JJ human) (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_) (NN equivalent))) (PP (TO to) (NP (NN _PROT2_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT2_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT2_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT2_) (NN _PROT2_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT2_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT2_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT2_) (NN _PROT2_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT1_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT2_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT1_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT2_) (NN _PROT2_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT1_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT1_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT2_) (NN _PROT2_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT1_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT_) (NN _PROT_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (DT The) (VBG resulting) (NN Trk) (NN variant)) (VP (VP (VBN recruited) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_) (NN equivalent))) (PP (TO to) (NP (NN _PROT_))))) (, ,) (VP (VBN maintained) (NP (NP (NN _PROT_) (NN binding)) (ADJP (JJ equivalent) (PP (TO to) (NP (NN _PROT_)))))) (, ,) (CC and) (ADVP (RB also)) (VP (VBD bound) (NP (JJ _PROT1_) (NN _PROT1_)) (, ,) (SBAR (IN although) (S (VP (PP (IN with) (NP (JJR lower) (NN affinity))) (VBN compared) (PP (IN with) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (ADVP (RB physically)) (VP (VBZ associates) (PP (IN with) (NP (NN _PROT2_))) (PP (IN through) (NP (NN Src) (NN homology) (CD 3) (NNS domains))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (NP (DT the) (JJ second)) (PP (IN of) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NNS experiments)) (VP (VBN designed) (S (VP (TO to) (VP (VB identify) (NP (ADJP (NN _PROT1_) (NN homology) (CD 3) (-LRB- -LRB-) (NN SH3) (-RRB- -RRB-) (JJ -binding)) (NNS molecules)))))))))))) (, ,) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN cloning)) (PP (IN of) (NP (NP (NN _PROT2_) (CD _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (JJ _PROT_) (NN _PROT_) (CD _PROT_)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT an) (NN HL60) (NN cDNA) (NN expression) (NN library))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (NP (DT the) (JJ second)) (PP (IN of) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NNS experiments)) (VP (VBN designed) (S (VP (TO to) (VP (VB identify) (NP (ADJP (NN _PROT1_) (NN homology) (CD 3) (-LRB- -LRB-) (NN SH3) (-RRB- -RRB-) (JJ -binding)) (NNS molecules)))))))))))) (, ,) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN cloning)) (PP (IN of) (NP (NP (NN _PROT_) (CD _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT an) (NN HL60) (NN cDNA) (NN expression) (NN library))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (NP (DT the) (JJ second)) (PP (IN of) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NNS experiments)) (VP (VBN designed) (S (VP (TO to) (VP (VB identify) (NP (ADJP (NN _PROT_) (NN homology) (CD 3) (-LRB- -LRB-) (NN SH3) (-RRB- -RRB-) (JJ -binding)) (NNS molecules)))))))))))) (, ,) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN cloning)) (PP (IN of) (NP (NP (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT an) (NN HL60) (NN cDNA) (NN expression) (NN library))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NNS Studies)) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))) (VP (VBD demonstrated) (NP (NP (DT a) (ADJP (RB highly) (JJ specific)) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (NN SH3) (NNS domains)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (S (NP (ADJP (FW In) (FW vitro)) (NN translation) (NNS studies)) (VP (VBD identified) (NP (DT the) (JJ 66-kDa) (NN protein)) (PP (IN as) (NP (NP (DT the) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT1_))))))) (, ,) (CC and) (S (NP (JJ subcellular) (NN fractionation) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (ADJP (RB mainly) (JJ present) (PP (IN in) (NP (DT the) (NN cytosol) (NN fraction)))) (, ,) (SBAR (IN although) (S (NP (JJ significant) (NNS amounts)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ present) (PP (IN in) (NP (NP (NN membrane)) (CC and) (NP (JJ nuclear) (NNS fractions)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (JJ main) (NN _PROT1_) (NN region)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN association)) (PP (IN with) (NP (NN _PROT2_))))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (DT the) (JJ carboxy-terminal) (NN SH3) (NN domain)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (JJ mitogenic) (NNS effects)) (PP (IN of) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PP (IN _PROT1_) (NP (NN _PROT1_)))))) (VP (VBP are) (VP (VBN mediated) (PP (IN through) (NP (NN cell) (NN surface) (NN _PROT2_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN Immunoprecipitation) (NNS experiments)) (VP (VBG employing) (NP (DT a) (JJ polyclonal) (NN _PROT1_) (NN antibody)))) (VP (VBD provided) (NP (JJ further) (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (JJ 60-kDa) (NN protein)) (VP (VBN isolated) (PP (IN in) (NP (DT this) (NN study))))) (VP (VBD was) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Further)) (, ,) (NP (NP (JJ polyclonal) (NNS antibodies)) (PP (TO to) (NP (JJ human) (NN _PROT1_)))) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (NP (DT the) (JJ mitogenic) (NN activity)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_))) (PP (IN on) (NP (JJ human) (NNS fibroblasts)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NN cell) (NN surface) (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PP (IN _PROT2_) (NP (NP (NN _PROT2_)) (VP (VBG mediating) (NP (PRP$ its) (JJ mitogenic) (NN activity))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT_) (NNS receptors))))) (VP (VBD revealed) (PP (IN by) (NP (NP (NN affinity) (NN crosslinking)) (CC and) (NP (NN immunoprecipitation)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_) (NN _PROT2_) (NNS receptors))))) (VP (VBD revealed) (PP (IN by) (NP (NP (NN affinity) (NN crosslinking)) (CC and) (NP (NN immunoprecipitation)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_) (NN _PROT2_) (NNS receptors))))) (VP (VBD revealed) (PP (IN by) (NP (NP (NN affinity) (NN crosslinking)) (CC and) (NP (NN immunoprecipitation)))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT2_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT2_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_AND_PROT2_) (NN _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT2_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT2_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (-LRB- _PROT_) (NN _PROT2_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_AND_PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT1_AND_PROT2_) (-RRB- _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (-LRB- _PROT_) (NN _PROT1_) (-RRB- _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBZ binds) (ADVP (RB independently)) (PP (TO to) (NP (NP (CD two) (JJ transmembrane) (NNS receptors)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (S (NP (DT both)) (VP (VBD co-expressed) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (JJ neuronal) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN _PROT2_)))))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP have) (VP (VBN utilized) (NP (NP (NN affinity) (NN crosslinking) (NNS agents)) (PP (IN with) (NP (NN 125I-NGF)))) (S (VP (TO to) (VP (VB detect) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS receptors)))) (PP (IN in) (NP (NP (NP (NP (JJ embryonic) (JJ spinal) (NN cord)) (CC and) (NP (NN brain))) (NNS tissues)) (VP (VBN enriched) (PP (IN in) (NP (DT the) (CD two) (NNS receptors)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT2_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT2_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT2_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT2_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT2_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT2_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT1_AND_PROT2_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT1_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT2_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT1_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT1_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT2_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT1_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ multimeric) (NNS complexes)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (NN affinity) (NN crosslinking))))))) (, ,) (NP (NP (NN immunoprecipitation)) (PP (IN of) (NP (JJ cross-linked) (NN _PROT_) (NNS complexes))) (PP (IN with) (NP (JJ _PROT1_) (NNS antibodies)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ selective) (NN immunoprecipitation)) (PP (IN of) (NP (VBN crosslinked) (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS receptors)) (VP (MD can) (ADVP (RB potentially)) (VP (VB interact))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PDT such) (DT an) (NN association)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ high) (NN affinity) (NN _PROT_) (NN binding) (NNS sites))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS receptors)) (VP (MD can) (ADVP (RB potentially)) (VP (VB interact))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PDT such) (DT an) (NN association)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ high) (NN affinity) (NN _PROT2_) (NN binding) (NNS sites))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS receptors)) (VP (MD can) (ADVP (RB potentially)) (VP (VB interact))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PDT such) (DT an) (NN association)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ high) (NN affinity) (NN _PROT2_) (NN binding) (NNS sites))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN Mechanism)) (PP (IN of) (NP (NN CDK) (NN activation)))) (VP (VBN revealed) (PP (IN by) (NP (NP (DT the) (NN structure)) (PP (IN of) (NP (DT a) (NN _PROT1_AND_PROT2_) (NN complex))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN crystal) (NN structure)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (JJ _PROT1_AND_PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN -ATP) (NN complex)))) (VP (VBZ has) (VP (VBN been) (VP (VBN determined) (PP (IN at) (NP (CD 2.3) (NN A) (NN resolution))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN crystal) (NN structure)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (JJ _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN -ATP) (NN complex)))) (VP (VBZ has) (VP (VBN been) (VP (VBN determined) (PP (IN at) (NP (CD 2.3) (NN A) (NN resolution))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN crystal) (NN structure)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN -ATP) (NN complex)))) (VP (VBZ has) (VP (VBN been) (VP (VBN determined) (PP (IN at) (NP (CD 2.3) (NN A) (NN resolution))))))) (. .))) |ET|
-1 |BT| (S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NP (NP (NN cDNA) (NN cloning)) (CC and) (NP (NN characterization)))) (PP (IN of) (NP (NP (DT a) (JJ human) (NN type) (NN II) (NN receptor)) (PP (IN for) (NP (NP (NP (NN BMPs)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB distantly) (JJ related) (PP (TO to) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (NN _PROT_) (NN _PROT_) (CD _PROT_) (NN _PROT_)) (PP (IN from) (NP (NN Caenorhabditis) (NNS elegans)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NP (NP (NN cDNA) (NN cloning)) (CC and) (NP (NN characterization)))) (PP (IN of) (NP (NP (DT a) (JJ human) (NN type) (NN II) (NN receptor)) (PP (IN for) (NP (NP (NP (NN BMPs)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB distantly) (JJ related) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN _PROT2_) (NN _PROT2_) (CD _PROT2_) (NN _PROT2_)) (PP (IN from) (NP (NN Caenorhabditis) (NNS elegans)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NP (NP (NN cDNA) (NN cloning)) (CC and) (NP (NN characterization)))) (PP (IN of) (NP (NP (DT a) (JJ human) (NN type) (NN II) (NN receptor)) (PP (IN for) (NP (NP (NP (NN BMPs)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB distantly) (JJ related) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT a) (NN _PROT2_) (NN _PROT2_) (CD _PROT2_) (NN _PROT2_)) (PP (IN from) (NP (NN Caenorhabditis) (NNS elegans)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (NN _PROT1_AND_PROT2_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT_))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (NN _PROT1_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT2_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT_))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (NN _PROT1_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT2_))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (NN _PROT1_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT2_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT_))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (NN _PROT1_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT2_))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (VBN transfected) (NN COS-1) (NNS cells))) (, ,) (NP (NP (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (NN _PROT_)) (, ,) (CC and) (ADVP (RBR less) (RB efficiently)) (NP (NN _PROT1_)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NN _PROT2_))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN _PROT1_AND_PROT2_))) (PP (TO to) (NP (NN _PROT_)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (JJ nontransfected) (NN cell) (NNS lines)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN _PROT1_))) (PP (TO to) (NP (NN _PROT2_)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (JJ nontransfected) (NN cell) (NNS lines)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN _PROT1_))) (PP (TO to) (NP (NN _PROT2_)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (JJ nontransfected) (NN cell) (NNS lines)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (DT a) (JJ transcriptional) (NN activation) (NN signal)) (VP (VBD was) (VP (VBN transduced) (PP (IN by) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN type) (CD I) (NP (NNS receptors)))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN by) (NP (NN _PROT2_)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (DT a) (JJ transcriptional) (NN activation) (NN signal)) (VP (VBD was) (VP (VBN transduced) (PP (IN by) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN type) (CD I) (NP (NNS receptors)))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN by) (NP (NN _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (DT a) (JJ transcriptional) (NN activation) (NN signal)) (VP (VBD was) (VP (VBN transduced) (PP (IN by) (NP (NN _PROT_))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN type) (CD I) (NP (NNS receptors)))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN by) (NP (NN _PROT1_AND_PROT2_)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN Crystal) (NN structure)) (PP (IN of) (NP (DT the) (JJ heterodimeric) (NN bZIP) (NN transcription) (NN factor) (CD _PROT1_AND_PROT2_)))) (VP (VBD bound) (PP (TO to) (NP (NN DNA))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS families)) (PP (IN of) (NP (JJ eukaryotic) (NN transcription) (NNS factors)))) (VP (VBP heterodimerize) (S (VP (TO to) (VP (VB form) (NP (NP (NNS complexes)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (NP (NN 5'-TGAGTCA-3) (POS ') (NN DNA) (NNS elements)))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN determined) (NP (NP (DT the) (NN X-ray) (NN crystal) (NN structure)) (PP (IN of) (NP (NP (DT a) (NN heterodimer)) (PP (IN of) (NP (NP (DT the) (NN bZIP) (NNS regions)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBD bound) (PP (TO to) (NP (NN DNA)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN Comparison)) (PP (IN of) (NP (DT the) (CD two) (ADJP (RB crystallographically) (JJ distinct)) (JJ protein-DNA) (NNS complexes)))) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (DT the) (JJ coiled-coil)) (VP (VBZ is) (ADVP (RB flexibly)) (VP (VBN joined) (PP (TO to) (NP (DT the) (JJ basic) (NNS regions))))))) (CC and) (SBAR (IN that) (S (NP (DT the) (NN _PROT1_AND_PROT2_) (NN heterodimer)) (VP (VBZ does) (RB not) (VP (VB recognize) (NP (NP (DT the) (JJ asymmetric) (CD 5'-TGAGTCA-3) (`` ') (NN recognition) (NN element)) (PP (IN in) (NP (DT a) (JJ unique) (NN orientation))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN protein) (NN _PROT1_)) (, ,) (NP (NP (DT a) (JJ key) (NN mediator)) (PP (IN of) (NP (NP (NN mitogenesis)) (CC and) (NP (NN differentiation))))) (, ,)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (CD 1-3)) (-RRB- -RRB-)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS proteins)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN 14-3-3) (NN family)) (PP (IN of) (NP (NNS proteins)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN 14-3-3) (NNS proteins))) (PP (IN in) (NP (NN Xenopus) (NNS oocytes)))) (VP (VP (VBD enhanced) (NP (NN _PROT1_) (NN activity))) (CC and) (VP (VBD promoted) (NP (JJ _PROT2_) (NN oocyte) (NN maturation))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN POU) (NNS domains)) (PP (IN of) (NP (DT the) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NN transcription) (NNS factors)))) (VP (VBP mediate) (NP (NP (JJ specific) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN POU) (NNS domains)) (PP (IN of) (NP (DT the) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NN transcription) (NNS factors)))) (VP (VBP mediate) (NP (NP (JJ specific) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN POU) (NNS domains)) (PP (IN of) (NP (DT the) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NN transcription) (NNS factors)))) (VP (VBP mediate) (NP (NP (JJ specific) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBD had) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ ubiquitous) (NN _PROT1_)) (CC and) (NP (DT the) (JJ lymphoid-specific) (NN _PROT2_)) (NP (NN transcription) (NNS factors))) (VP (VBP stimulate) (NP (NN transcription)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ stable) (NN preinitiation) (NN complex) (NN formation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB therefore)) (VP (VBN investigated) (SBAR (IN whether) (S (NP (DT the) (NN octamer) (NN binding) (NNS proteins)) (VP (MD might) (ADVP (RB physically)) (VP (VB interact) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN factor))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB therefore)) (VP (VBN investigated) (SBAR (IN whether) (S (NP (DT the) (NN octamer) (NN binding) (NNS proteins)) (VP (MD might) (ADVP (RB physically)) (VP (VB interact) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN factor))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB therefore)) (VP (VBN investigated) (SBAR (IN whether) (S (NP (DT the) (NN octamer) (NN binding) (NNS proteins)) (VP (MD might) (ADVP (RB physically)) (VP (VB interact) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN factor))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ several) (JJ different) (JJ experimental) (NNS systems))))) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB efficiently)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ several) (JJ different) (JJ experimental) (NNS systems))))) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB efficiently)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ several) (JJ different) (JJ experimental) (NNS systems))))) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB efficiently)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN POU) (NN homeodomain)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (ADJP (RB evolutionarily) (VBN conserved)) (JJ C-terminal) (NN core) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))) (VP (VBP are) (ADJP (CC both) (ADJP (JJ required)) (CC and) (ADJP (JJ sufficient)) (PP (IN for) (NP (DT the) (NN interaction))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN _PROT1_) (NN POU) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB highly) (JJ homologous) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN POU) (NN domain))))))) (, ,)) (ADVP (RB likewise)) (VP (VBZ mediates) (NP (NP (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (NN _PROT1_) (NN POU) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB highly) (JJ homologous) (PP (TO to) (NP (DT the) (NN _PROT_) (NN POU) (NN domain))))))) (, ,)) (ADVP (RB likewise)) (VP (VBZ mediates) (NP (NP (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN _PROT_) (NN POU) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RB highly) (JJ homologous) (PP (TO to) (NP (DT the) (NN _PROT1_) (NN POU) (NN domain))))))) (, ,)) (ADVP (RB likewise)) (VP (VBZ mediates) (NP (NP (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT1_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT2_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT1_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT2_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT1_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT2_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT1_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT2_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT1_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT2_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT The) (NN interaction)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN observed) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN as) (S (S (NP (NN _PROT_)) (VP (MD can) (VP (VB be) (VP (VBN co-precipitated) (PP (IN with) (NP (NN _PROT_))) (PP (IN from) (NP (VBN co-transfected) (NN Cos1) (NNS cells))))))) (CC and) (S (NP (NN _PROT1_)) (VP (VBZ co-immunoprecipitates) (PP (IN with) (NP (NP (DT the) (JJ endogenous) (NN _PROT2_)) (PP (IN from) (NP (NN HeLa) (NNS cells))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN Co-transfection)) (PP (IN of) (NP (NP (JJ human) (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN expression) (NNS vectors)))) (PP (IN into) (NP (NN B) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ synergistic) (NN activation)) (PP (IN of) (NP (NP (DT an) (NN octamer) (NN motif)) (VP (VBG containing) (NP (NN promoter))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (DT the) (JJ _PROT1_) (NN transcription) (NN factor) (NN _PROT2_))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (DT the) (NN _PROT_) (NN protein)))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (DT the) (JJ _PROT1_) (NN transcription) (NN factor) (NN _PROT_))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN protein)))))) (. .)))) |ET|
+1 |BT| (S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (DT the) (JJ _PROT_) (NN transcription) (NN factor) (NN _PROT1_))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN protein)))))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (NN _PROT1_) (NN gene) (NN product)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ nuclear) (NN phosphoprotein)) (SBAR (WHNP (WDT that)) (S (VP (VBZ regulates) (NP (NN cell) (NN cycle) (NN progression)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ lymphoid-specific) (NN _PROT2_) (NN transcription) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ regulates) (NP (JJ inducible) (NN gene) (NN expression)) (PP (IN during) (NP (NN T) (NN cell) (NN activation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ contains) (NP (NP (DT a) (NN sequence) (NN motif)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADJP (RB highly) (JJ related) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN binding) (NNS sites)) (PP (IN of) (NP (JJ several) (JJ viral) (NNS oncoproteins))))))) (CC and) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN pocket) (NN region)) (PP (IN of) (NP (NN _PROT_))))) (ADVP (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ contains) (NP (NP (DT a) (NN sequence) (NN motif)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADJP (RB highly) (JJ related) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN binding) (NNS sites)) (PP (IN of) (NP (JJ several) (JJ viral) (NNS oncoproteins))))))) (CC and) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN pocket) (NN region)) (PP (IN of) (NP (NN _PROT2_))))) (ADVP (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ contains) (NP (NP (DT a) (NN sequence) (NN motif)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADJP (RB highly) (JJ related) (PP (TO to) (NP (NP (DT the) (NN _PROT1_) (NN binding) (NNS sites)) (PP (IN of) (NP (JJ several) (JJ viral) (NNS oncoproteins))))))) (CC and) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN pocket) (NN region)) (PP (IN of) (NP (NN _PROT2_))))) (ADVP (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBZ binds) (ADVP (RB exclusively)) (PP (TO to) (NP (NP (DT the) (JJ underphosphorylated) (NN form)) (PP (IN of) (NP (NN _PROT2_)))))) (CC and) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (NN _PROT_) (NNS mutants)) (VP (VBN derived) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN retinoblastoma)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VP (VBZ binds) (ADVP (RB exclusively)) (PP (TO to) (NP (NP (DT the) (JJ underphosphorylated) (NN form)) (PP (IN of) (NP (NN _PROT_)))))) (CC and) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (NN _PROT2_) (NNS mutants)) (VP (VBN derived) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN retinoblastoma)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VP (VBZ binds) (ADVP (RB exclusively)) (PP (TO to) (NP (NP (DT the) (JJ underphosphorylated) (NN form)) (PP (IN of) (NP (NN _PROT1_)))))) (CC and) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (NN _PROT2_) (NNS mutants)) (VP (VBN derived) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN retinoblastoma)))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN Co-immunoprecipitation) (NNS experiments)) (VP (VBD demonstrated) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (PP (IN in) (NP (VBG resting) (JJ normal) (JJ human) (NN T) (NNS cells)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN After) (NP (NN T) (NN cell) (NN activation))) (, ,) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN correlated) (ADVP (RB temporally)) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ _PROT_) (NN transcription))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN After) (NP (NN T) (NN cell) (NN activation))) (, ,) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN correlated) (ADVP (RB temporally)) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ _PROT2_) (NN transcription))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN After) (NP (NN T) (NN cell) (NN activation))) (, ,) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN _PROT1_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN correlated) (ADVP (RB temporally)) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ _PROT2_) (NN transcription))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NP (DT a) (JJ phosphorylation-defective) (NN form)) (PP (IN of) (NP (NN _PROT1_)))))) (VP (VBD inhibited) (NP (JJ _PROT2_) (NN transcription)) (PP (IN during) (NP (NN T) (NN cell) (NN activation))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (DT a) (JJ lineage-restricted) (NN _PROT2_) (NN transcription) (NN factor)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (ADJP (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (JJ _PROT1_)) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (ADVP (RB specifically)) (VP (VBZ recognizes) (NP (NP (DT the) (NNS PSEs)) (PP (IN of) (NP (CC both) (NP (NN RNA) (NN polymerase) (NN II-)) (CC and) (NP (ADJP (NN RNA) (NN polymerase) (JJ III-transcribed)) (NP (NP (JJ small) (JJ nuclear) (NN RNA)) (PRN (-LRB- -LRB-) (NP (NN snRNA)) (-RRB- -RRB-))) (NNS genes))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (VP (VBN purified) (PP (IN from) (NP (JJ human) (NN HeLa) (NNS cells))))) (VP (VBZ is) (NP (NP (DT a) (JJ multisubunit) (NN complex)) (PP (IN of) (NP (NP (CD four) (NNS polypeptides)) (VP (VBN designated) (S (NP (NP (NN _PROT2_) (NN _PROT_)) (, ,) (NP (NN -beta)) (, ,) (NP (NN -gamma)) (, ,) (CC and) (NP (NN -delta)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (VP (VBN purified) (PP (IN from) (NP (JJ human) (NN HeLa) (NNS cells))))) (VP (VBZ is) (NP (NP (DT a) (JJ multisubunit) (NN complex)) (PP (IN of) (NP (NP (CD four) (NNS polypeptides)) (VP (VBN designated) (S (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN -beta)) (, ,) (NP (NN -gamma)) (, ,) (CC and) (NP (NN -delta)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (VP (VBN purified) (PP (IN from) (NP (JJ human) (NN HeLa) (NNS cells))))) (VP (VBZ is) (NP (NP (DT a) (JJ multisubunit) (NN complex)) (PP (IN of) (NP (NP (CD four) (NNS polypeptides)) (VP (VBN designated) (S (NP (NP (NN _PROT1_AND_PROT2_) (NN _PROT2_)) (, ,) (NP (NN -beta)) (, ,) (NP (NN -gamma)) (, ,) (CC and) (NP (NN -delta)))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP report) (NP (NP (NP (DT the) (NP (NP (NN isolation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT2_) (NN delta))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ functional) (NNS studies)) (PP (IN with) (NP (NP (JJ cognate) (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VBP recognize) (NP (DT the) (JJ native) (NN _PROT_) (NN complex)) (PP (IN in) (NP (NN HeLa) (NNS extracts)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP report) (NP (NP (NP (DT the) (NP (NP (NN isolation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ functional) (NNS studies)) (PP (IN with) (NP (NP (JJ cognate) (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VBP recognize) (NP (DT the) (JJ native) (NN _PROT2_) (NN complex)) (PP (IN in) (NP (NN HeLa) (NNS extracts)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP report) (NP (NP (NP (DT the) (NP (NP (NN isolation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ functional) (NNS studies)) (PP (IN with) (NP (NP (JJ cognate) (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VBP recognize) (NP (DT the) (JJ native) (NN _PROT2_) (NN complex)) (PP (IN in) (NP (NN HeLa) (NNS extracts)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS studies)) (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (DT the) (CD four) (NN _PROT1_) (NNS subunits)) (VP (ADVP (RB originally)) (VBN found) (S (VP (TO to) (VP (VB copurify) (PP (IN during) (NP (JJ conventional) (NN chromatography))) (ADVP (RB indeed)) (PP (IN form) (NP (DT a) (ADJP (RB tightly) (VBN associated)) (NN complex)))))))))))) (: ;) (S (NP (PRP they)) (ADVP (RB further)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN _PROT2_)) (ADJP (RB so) (VBN defined))) (, ,) (PP (VBG including) (NP (NP (DT the) (NP (NP (NN gamma)) (CC and) (NP (NN delta))) (NNS subunits)) (ADVP (RB specifically)))) (, ,)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN transcription)) (PP (IN of) (NP (CC both) (NP (NN class) (CD II)) (CC and) (NP (NN class) (CD III)) (NP (NN snRNA) (NNS genes)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT2_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT2_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT2_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT2_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT2_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT1_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT1_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT1_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT1_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN Immunoprecipitation) (NNS assays)) (ADVP (RB also)) (VP (VBP show) (NP (NP (DT a) (JJ weak) (JJ substoichiometric) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ previous) (NN report)) (PP (IN of) (NP (NP (NP (DT a) (JJ _PROT_) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (JJ substoichiometric) (NNS levels)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT a) (NN component)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))) (ADJP (JJ identical) (PP (IN in) (NP (NN sequence))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN gamma)) (VP (VBN reported) (ADVP (RB here)))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT2_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT2_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT1_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT2_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT1_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT1_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT1_AND_PROT2_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT1_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT1_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT1_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT2_)) (CC and) (NP (JJ TATA-bound) (NN _PROT_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT1_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NN Glutathione) (NN S-transferase)) (JJ pulldown) (NNS assays)) (ADVP (RB further)) (VP (VBP indicate) (NP (NP (ADJP (RB relatively) (JJ strong)) (JJ direct) (NNS interactions)) (PP (IN of) (NP (CC both) (NP (JJ recombinant) (NN _PROT_) (NN gamma)) (CC and) (NP (NN _PROT_) (NN delta)))) (PP (IN with) (NP (NN _PROT_)))) (, ,) (S (ADJP (JJ consistent) (PP (CC either) (PP (IN with) (NP (NP (DT the) (JJ natural) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (DT a) (JJ semistable) (JJ _PROT_) (NN factor) (NN complex))))) (CC or) (PP (IN with) (NP (NP (JJ possible) (JJ functional) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ PSE-bound) (NN _PROT1_)) (CC and) (NP (JJ TATA-bound) (NN _PROT2_))) (PP (IN during) (NP (NN promoter) (NN activation))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT2_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT2_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT1_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT2_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT1_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT1_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT1_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT1_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT1_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT1_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN depleted) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (NNS factors))))))) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN U1) (NN promoter)))) (VP (VBZ is) (VP (VBN restored) (PP (PP (IN by) (NP (JJ recombinant) (NN _PROT_))) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN transcription)) (PP (IN of) (NP (NN class) (CD II) (NN snRNA) (NNS genes)))) (VP (VBZ requires) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (ADJP (JJ different) (PP (IN from) (NP (NP (DT the) (NN one)) (VP (VBN used) (PP (IN for) (NP (JJ mRNA-encoding) (NNS genes)))))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT The) (NN _PROT1_) (CD _PROT1_) (NN glucose) (NN transporter)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT The) (NN _PROT1_) (CD _PROT1_) (NN glucose) (NN transporter)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (DT The) (NN _PROT_) (CD _PROT_) (NN glucose) (NN transporter)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT A) (VBN truncated) (NN version)) (PP (IN of) (NP (NP (DT the) (JJ integral) (NN membrane) (NN glycoprotein)) (NP (NN _PROT1_) (CD _PROT1_) (-LRB- -LRB-) (CD _PROT2_) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN synthesized) (PP (IN in) (NP (DT a) (NN rabbit) (NN reticulocyte) (NN translation) (NN system))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ canine) (JJ pancreatic) (NNS microsomes)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (VBG Following) (NP (NP (NN immunoprecipitation)) (PP (IN with) (NP (DT an) (NN anticalnexin) (NN antiserum))))) (, ,) (NP (DT a) (JJ cross-linker-independent) (NN association)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN anti-calnexin) (NN antiserum)) (VP (VBD immunoprecipitated) (NP (NP (DT a) (JJ UV-dependent) (NN cross-linking) (NN product)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NP (DT a) (NN protein)) (PP (IN of) (NP (QP (RB approximately) (CD 60)) (NN kDa)))) (VP (VBN designated) (S (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (JJ _PROT_) (NN _PROT_)) (PP (IN of) (NP (CD 60) (NN kDa)))) (-RRB- -RRB-)))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN anti-calnexin) (NN antiserum)) (VP (VBD immunoprecipitated) (NP (NP (DT a) (JJ UV-dependent) (NN cross-linking) (NN product)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NP (DT a) (NN protein)) (PP (IN of) (NP (QP (RB approximately) (CD 60)) (NN kDa)))) (VP (VBN designated) (S (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (JJ _PROT2_) (NN _PROT2_)) (PP (IN of) (NP (CD 60) (NN kDa)))) (-RRB- -RRB-)))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN anti-calnexin) (NN antiserum)) (VP (VBD immunoprecipitated) (NP (NP (DT a) (JJ UV-dependent) (NN cross-linking) (NN product)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (NP (DT a) (NN protein)) (PP (IN of) (NP (QP (RB approximately) (CD 60)) (NN kDa)))) (VP (VBN designated) (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (JJ _PROT2_) (NN _PROT2_)) (PP (IN of) (NP (CD 60) (NN kDa)))) (-RRB- -RRB-)))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_AND_PROT2_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT2_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT2_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT2_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT2_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT2_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT1_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT2_) (NNS interactions))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT1_AND_PROT2_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT1_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT1_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT2_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT1_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT1_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT2_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (CC Both) (NP (DT the) (NN _PROT_)) (CC and) (NP (DT the) (CD _PROT_) (NNS interactions))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group)) (PP (IN on) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (JJ many) (NN _PROT2_) (NNS interactions))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT A) (NN _PROT1_) (NN mutant)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (VP (VBN glycosylated)))))) (PRN (-LRB- -LRB-) (NP (NN AGGT155)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB associate) (PP (IN with) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT A) (NN _PROT1_) (NN mutant)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (VP (VBN glycosylated)))))) (PRN (-LRB- -LRB-) (NP (NN AGGT155)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB associate) (PP (IN with) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT A) (NN _PROT_) (NN mutant)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (VP (VBN glycosylated)))))) (PRN (-LRB- -LRB-) (NP (NN AGGT155)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB associate) (PP (IN with) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT the) (JJ soluble) (NN homologue)) (PP (IN of) (NP (NN _PROT2_)))) (, ,)) (VP (VBD was) (ADVP (RB also)) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_))) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (DT the) (NN protein)) (VP (VBD bore) (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT the) (JJ soluble) (NN homologue)) (PP (IN of) (NP (NN _PROT_)))) (, ,)) (VP (VBD was) (ADVP (RB also)) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (DT the) (NN protein)) (VP (VBD bore) (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT the) (JJ soluble) (NN homologue)) (PP (IN of) (NP (NN _PROT1_)))) (, ,)) (VP (VBD was) (ADVP (RB also)) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (DT the) (NN protein)) (VP (VBD bore) (NP (DT a) (ADJP (RB correctly) (VBN modified)) (NN oligosaccharide) (NN group))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP interact) (PP (IN with) (NP (NN _PROT_) (CD _PROT_))) (PP (IN in) (NP (DT a) (JJ glycosylation-dependent) (NN manner)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_) (CD _PROT2_))) (PP (IN in) (NP (DT a) (JJ glycosylation-dependent) (NN manner)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_) (CD _PROT2_))) (PP (IN in) (NP (DT a) (JJ glycosylation-dependent) (NN manner)))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ _PROT1_AND_PROT2_) (JJ _PROT1_AND_PROT2_) (NN _PROT1_AND_PROT2_) (JJ _PROT1_AND_PROT2_) (NN _PROT2_)) (: :) (NP (NP (DT a) (ADJP (ADJP (JJ ligand)) (CC and) (ADJP (JJ specific))) (NN activator)) (PP (IN of) (NP (DT the) (NN tyrosine) (NN kinase) (NN receptor) (NN _PROT_)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT_)) (: :) (NP (NP (DT a) (ADJP (ADJP (JJ ligand)) (CC and) (ADJP (JJ specific))) (NN activator)) (PP (IN of) (NP (DT the) (NN tyrosine) (NN kinase) (NN receptor) (NN _PROT2_)))) (. .)))) |ET|
+1 |BT| (S1 (S (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (: :) (NP (NP (DT a) (ADJP (ADJP (JJ ligand)) (CC and) (ADJP (JJ specific))) (NN activator)) (PP (IN of) (NP (DT the) (NN tyrosine) (NN kinase) (NN receptor) (NN _PROT2_)))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (DT The) (NN tyrosine) (NNS kinases)) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT1_)))) (PRN (-LRB- -LRB-) (CC or) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endothelial) (JJ cell-specific) (NNS receptors)) (PP (IN with) (NP (NP (CD seven) (JJ immunoglobulin-like) (NNS domains)) (CC and) (NP (DT a) (JJ split) (NN kinase) (NN domain))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT2_) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN in) (NP (JJ vascular) (NN development)))))))))) (: ;) (S (NP (DT these) (CD two) (NNS receptors)) (VP (VP (VBP bind)) (CC and) (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_AND_PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT This) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (, ,)) (ADVP (RB specifically)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN _PROT1_)))))) (, ,) (VP (VBZ stimulates) (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (JJ mammalian) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ promotes) (NP (NP (DT the) (NN mitogenesis)) (PP (IN of) (NP (JJ human) (NN lung) (JJ endothelial) (NNS cells))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (ADVP (RB appreciably)) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (ADVP (RB appreciably)) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NN _PROT_)) (VP (VBZ fails) (S (VP (TO to) (VP (VB bind) (ADVP (RB appreciably)) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN substrate)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN plasticity)))) (PP (IN of) (NP (JJ neuronal) (NNS connections))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ several) (NN signal) (NN transduction) (NNS pathways))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ yeast-based) (NN cloning) (NN system))) (, ,) (NP (NP (DT the) (JJ only) (JJ strong) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NN _PROT1_)) (VP (VBZ phosphorylates) (NP (NN _PROT2_)) (PP (IN on) (NP (NN serine) (CD 41))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT1_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT2_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT1_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT2_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT1_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT1_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT2_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT1_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ N-terminal) (JJ third)) (PP (IN of) (NP (NN _PROT_)))) (ADVP (RB alone)) (VP (VBD bound) (NP (NN _PROT_)) (ADVP (ADVP (RBR more) (RB strongly)) (SBAR (IN than) (SINV (VBD did) (NP (JJ intact) (NN _PROT1_))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (POS 's)) (NN C-terminus)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN _PROT2_))))))))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (DT These) (NNS results)) (, ,) (PP (IN along) (PP (IN with) (NP (JJ other) (JJ recent) (NNS findings)))) (, ,) (VP (VBP suggest) (NP (NP (DT a) (JJ novel) (NN role)) (PP (IN for) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))) (. .))) |ET|
+1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT2_)) (CC and) (NP (JJ _PROT_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT2_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT2_)) (CC and) (NP (JJ _PROT_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT2_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (JJ Discrete) (NN protein) (NNS interactions)) (PP (IN with) (NP (DT the) (NN _PROT_) (NN complex))) (PP (IN in) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT2_) (JJ myeloid) (NN cell) (NN proliferation)))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (JJ Hemopoietic) (NN cell) (NN proliferation)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NP (NN non-tyrosine)) (CC and) (NP (NN tyrosine) (NNS kinases))) (SBAR (WHNP (WDT that)) (S (VP (VBP signal) (PP (IN via) (NP (NP (ADJP (ADJP (JJ uncommon)) (CC and) (ADJP (JJ common))) (NNS sets)) (PP (IN of) (NP (NP (JJ downstream) (NN effector) (NNS molecules)) (PP (VBG including) (NP (DT the) (NN _PROT1_AND_PROT2_))))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex))) (PP (IN with) (NP (NN signaling) (NNS proteins))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NP (NP (NN non-tyrosine)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (NNS receptors)) (VP (VBG leading) (PP (TO to) (NP (JJ myeloid) (NN cell) (NN proliferation))))))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT2_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT2_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
-1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (, ,)) (VP (VBP induce) (NP (NN _PROT_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (, ,)) (VP (VBP induce) (NP (NN _PROT2_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
+1 |BT| (S1 (S (PP (IN By) (S (VP (VBG using) (NP (DT the) (ADJP (NN growth) (NN factor) (JJ dependent)) (NN M-07e) (NN cell) (NN line))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (NNS ligands)) (, ,) (ADVP (RB namely))) (: :) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (, ,)) (VP (VBP induce) (NP (NN _PROT2_) (NN tyrosine) (NN phosphorylation)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN In) (NP (DT these) (NNS cells))) (NP (DT the) (NN adaptor) (NN protein) (NN _PROT1_)) (ADVP (RB constitutively)) (VP (VBZ binds) (NP (NP (DT a) (JJ substantial) (NN fraction)) (PP (IN of) (NP (NN _PROT2_)))) (PP (IN through) (NP (DT the) (JJ N-terminal) (NN SH3) (NN domain))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_AND_PROT2_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT2_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT2_) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT2_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT2_) (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT1_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT1_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT2_) (NN _PROT_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT1_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT_) (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ stable) (NN _PROT_) (NN complex)) (VP (VBZ interacts) (, ,) (PP (IN through) (NP (DT the) (NN _PROT_) (NN SH2) (NN domain))) (, ,) (PP (IN with) (NP (DT the) (JJ _PROT1_) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN _PROT1_)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT a) (NN _PROT2_) (NN complex)) (VP (VBG containing) (NP (NN _PROT_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN _PROT1_)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT a) (NN _PROT_) (NN complex)) (VP (VBG containing) (NP (NN _PROT2_))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN _PROT_)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT a) (NN _PROT1_) (NN complex)) (VP (VBG containing) (NP (NN _PROT2_))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS experiments)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ mediates) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (NN _PROT_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS experiments)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ mediates) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT2_)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS experiments)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ mediates) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT1_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT2_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT1_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT2_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT1_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT2_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT1_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT1_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT2_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT1_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT1_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT2_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT1_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (ADVP (RB Moreover)) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (, ,) (PP (IN upon) (NP (NN _PROT_) (NN stimulation))) (, ,) (NP (DT the) (NN _PROT_) (NN complex)) (VP (VBZ recruits) (NP (NN _PROT1_)) (, ,) (ADVP (RB probably)) (PP (IN via) (NP (NN _PROT2_)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT2_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT1_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT2_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT1_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT1_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT1_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT1_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT1_AND_PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (PP (IN By) (NP (NN contrast))) (NP (NP (DT the) (NN _PROT_) (NN exchanger) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN _PROT_) (NNS immunoprecipitates)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_AND_PROT2_))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ different) (NNS complexes))))))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (VP (VBN Taken) (ADVP (RB together)))) (NP (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN coupling)) (CC both) (NP (NN tyrosine))) (CC and) (NP (NN non-tyrosine) (NN kinase) (NNS receptors))) (PP (TO to) (NP (JJ downstream) (NN effector) (NNS molecules)))))))) (CC and) (SBAR (IN that) (S (NP (JJ different) (NN signaling) (NNS molecules)) (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_) (NN complex))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NN non-tyrosine)) (CC or) (NP (NN tyrosine) (NN kinase))) (NNS receptors)) (VP (VBP are) (VP (VBN activated)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (VP (VBN Taken) (ADVP (RB together)))) (NP (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN coupling)) (CC both) (NP (NN tyrosine))) (CC and) (NP (NN non-tyrosine) (NN kinase) (NNS receptors))) (PP (TO to) (NP (JJ downstream) (NN effector) (NNS molecules)))))))) (CC and) (SBAR (IN that) (S (NP (JJ different) (NN signaling) (NNS molecules)) (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_) (NN complex))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NN non-tyrosine)) (CC or) (NP (NN tyrosine) (NN kinase))) (NNS receptors)) (VP (VBP are) (VP (VBN activated)))))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (VP (VBN Taken) (ADVP (RB together)))) (NP (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN coupling)) (CC both) (NP (NN tyrosine))) (CC and) (NP (NN non-tyrosine) (NN kinase) (NNS receptors))) (PP (TO to) (NP (JJ downstream) (NN effector) (NNS molecules)))))))) (CC and) (SBAR (IN that) (S (NP (JJ different) (NN signaling) (NNS molecules)) (VP (VBP interact) (PP (IN with) (NP (NN _PROT1_AND_PROT2_) (NN complex))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NN non-tyrosine)) (CC or) (NP (NN tyrosine) (NN kinase))) (NNS receptors)) (VP (VBP are) (VP (VBN activated)))))))))) (. .))) |ET|
-1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (JJ _PROT2_) (NN _PROT_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
+1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (JJ _PROT2_) (NN _PROT2_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (DT the) (JJ _PROT_) (NN _PROT_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT2_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (JJ _PROT1_AND_PROT2_) (NN _PROT2_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT2_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
-1 |BT| (S1 (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (JJ _PROT_) (JJ _PROT_) (NN _PROT_)) (CC and) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT1_) (NN Identification)) (PP (IN of) (NP (NP (CD two) (NN ligand) (NN binding) (NNS domains)) (PP (IN in) (NP (JJ soluble) (NN _PROT2_))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (CC and) (NP (JJ chemical) (NN cross-linking))))))) (. .)))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT2_) (NN _PROT1_AND_PROT2_) (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT_) (NN _PROT1_) (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT_) (NN _PROT1_) (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT The) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells))))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN glycosylated)) (NN protein)) (, ,) (VP (VBG possessing) (NP (NN binding) (NN ability)) (PP (IN for) (NP (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (CD Two) (JJ distinct) (NN ligand) (NN binding) (NNS domains)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (NP (JJ proteolytic) (NNS digests)) (PP (IN of) (NP (DT the) (NN receptor))))) (PP (IN by) (NP (NP (NN affinity) (NN separation)) (PP (IN on) (NP (JJ immobilized) (NN _PROT2_)))))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS results)) (, ,) (VP (VBN obtained) (PP (IN from) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ experimental) (NNS techniques)))))) (, ,)) (VP (VBP highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (CD two) (JJ distinct) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN _PROT2_))))))) (PP (IN in) (NP (VBG binding) (NNS _PROT_)))))) (. .))) |ET|
-1 |BT| (S1 (S (S (NP (NP (DT These) (NNS results)) (, ,) (VP (VBN obtained) (PP (IN from) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ experimental) (NNS techniques)))))) (, ,)) (VP (VBP highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (CD two) (JJ distinct) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT_))))))) (PP (IN in) (NP (VBG binding) (NNS _PROT2_)))))) (. .))) |ET|
+1 |BT| (S1 (S (S (NP (NP (DT These) (NNS results)) (, ,) (VP (VBN obtained) (PP (IN from) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ experimental) (NNS techniques)))))) (, ,)) (VP (VBP highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (CD two) (JJ distinct) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT1_))))))) (PP (IN in) (NP (VBG binding) (NNS _PROT2_)))))) (. .))) |ET|
